MedTrace Logo

Registry HBOT in DFU

NCT06693180 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-11-18

No results posted yet for this study

Summary

Overview of available data to assess the benefits of HBOT to DFU patients

Conditions

  • Diabetic Foot Ulcers

Interventions

OTHER

HBOT

Hyperbaric Oxygen Therapy

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Joost R Meijering, MD · Amsterdam University Medical Center

  • Dirk T Ubbink, MD, PhD · Amsterdam University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06693180 on ClinicalTrials.gov